Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,706.71
1,682.00
1,655.44
1,421.81
1,459.78
1,555.29
1,486.85
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,706.71
1,682.00
1,655.44
1,421.81
1,459.78
1,555.29
1,486.85
Raw Material Cost
911.74
886.08
999.30
887.70
885.83
903.81
1,024.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
98.14
95.84
74.35
34.33
32.21
34.04
40.91
Selling and Distribution Expenses
515.22
608.93
602.48
604.58
515.32
492.69
629.92
Other Expenses
-4.50
-2.80
-3.76
0.32
-2.91
-1.89
-3.28
Total Expenditure (Excl Depreciation)
1,480.14
1,562.81
1,638.50
1,529.86
1,404.31
1,411.63
1,662.10
Operating Profit (PBDIT) excl Other Income
226.6
119.2
16.9
-108.10000000000001
55.5
143.7
-175.3
Other Income
54.50
20.88
59.82
-14.57
32.69
10.30
-81.01
Operating Profit (PBDIT)
378.20
224.78
162.04
-33.51
147.64
241.95
-153.24
Interest
98.14
95.84
74.35
34.33
32.21
34.04
40.91
Exceptional Items
-1.64
5.05
-20.47
3.63
-5.00
0.00
-137.70
Gross Profit (PBDT)
794.98
795.92
656.14
534.11
573.95
651.48
462.75
Depreciation
97.12
84.71
82.00
88.82
88.11
87.42
101.87
Profit Before Tax
181.30
49.28
-14.78
-153.03
22.32
120.49
-433.72
Tax
8.84
40.17
45.26
25.89
12.35
43.90
29.94
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
184.36
24.54
-50.73
-152.38
29.74
130.05
-433.62
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
184.36
24.54
-50.73
-152.38
29.74
130.05
-433.62
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
12.45
7.31
10.68
-6.10
-8.35
-15.25
-44.30
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
196.81
31.84
-40.05
-158.48
21.38
114.81
-477.91
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
1,596.65
1,378.30
1,375.18
1,539.51
1,837.76
1,915.53
1,943.54
Earnings per share (EPS)
1.54
0.21
-0.42
-1.38
0.22
1.04
-3.66
Diluted Earnings per share
1.54
0.21
-0.42
-1.38
0.22
1.04
-3.66
Operating Profit Margin (Excl OI)
13.28%
7.09%
1.22%
-7.58%
1.84%
9.27%
-11.71%
Gross Profit Margin
16.31%
7.97%
4.06%
-4.52%
7.56%
13.37%
-22.32%
PAT Margin
10.8%
1.46%
-3.06%
-10.72%
2.04%
8.36%
-29.16%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 1.47% vs 1.61% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 518.87% vs 179.50% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 58.75% vs 99.51% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 2.40% vs 28.94% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Saudi Pharmaceutical Industries & Medical Appliances Corp. With
Figures in Million
Consolidate Annual Results
Change(SAR)
Change(%)
Net Sales
1,706.71
0
1,706.71
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,706.71
0
1,706.71
Raw Material Cost
911.74
0
911.74
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
98.14
0
98.14
Selling and Distribution Expenses
515.22
0
515.22
Other Expenses
-4.50
0.00
-4.50
Total Expenditure (Excl Depreciation)
1,480.14
0
1,480.14
Operating Profit (PBDIT) excl Other Income
226.57
0.00
226.57
Other Income
54.50
0
54.50
Operating Profit (PBDIT)
378.20
0
378.20
Interest
98.14
0
98.14
Exceptional Items
-1.64
0
-1.64
Gross Profit (PBDT)
794.98
0
794.98
Depreciation
97.12
0
97.12
Profit Before Tax
181.30
0
181.30
Tax
8.84
0
8.84
Provisions and contingencies
0
0
0.00
Profit After Tax
184.36
0
184.36
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
184.36
0
184.36
Share in Profit of Associates
0
0
0.00
Minority Interest
12.45
0
12.45
Other related items
0.00
0.00
0.00
Consolidated Net Profit
196.81
0
196.81
Equity Capital
0
0
0.00
Face Value
10.00
0
0.00
Reserves
1,596.65
0
1,596.65
Earnings per share (EPS)
1.54
0
1.54
Diluted Earnings per share
1.54
0
1.54
Operating Profit Margin (Excl OI)
13.28%
0%
0.00
13.28%
Gross Profit Margin
16.31%
0%
0.00
16.31%
PAT Margin
10.80%
0%
0.00
10.80%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 170.67 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 1.47% vs 1.61% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 19.68 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 518.87% vs 179.50% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 32.37 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 58.75% vs 99.51% in Dec 2024
Annual - Interest
Interest 9.81 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 2.40% vs 28.94% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.28%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






